Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Current Cancer Drug Targets|February 16, 2006
Estrogen receptor alpha: impact of ligands on intracellular shuttling and turnover rate in breast cancer cellsGuy Leclercq, Marc Lacroix, Ioanna Laïos, et al.
Molecular and Cellular Endocrinology|June 6, 2008
Calmodulin, a regulatory partner of the estrogen receptor alpha in breast cancer cellsDominique Gallo, Yves Jacquot, Guy Laurent, et al.
Expert Opinion on Drug Safety|May 9, 2008
Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone healthFabrice Journé, Jean-Jacques Body, Guy Leclercq, et al.
Maturitas|August 5, 2011
A critical view of the effects of phytoestrogens on hot flashes and breast cancer riskPascale This, Patricia de Cremoux, Guy Leclercq, et al.
Maturitas|November 16, 2010
Lack of sufficient information on the specificity and selectivity of commercial phytoestrogens preparations for therapeutic purposesGuy Leclercq, Patricia de Cremoux, Pascale This, et al.
Maturitas|January 19, 2010
Controversies concerning the use of phytoestrogens in menopause management: bioavailability and metabolismPatricia de Cremoux, Pascale This, Guy Leclercq, et al.
Steroids|March 12, 2003
Decrease of estrogen receptor expression and associated ERE-dependent transcription in MCF-7 breast cancer cells after oligomycin treatmentHye-Sook Seo, Fabrice Journé, Denis Larsimont, et al.
Molecular and Cellular Endocrinology|October 27, 2004
Ligand-independent and agonist-mediated degradation of estrogen receptor-alpha in breast carcinoma cells: evidence for distinct degradative pathwaysDenis Nonclercq, Fabrice Journé, Jean-Jacques Body, et al.
Breast Cancer Research and Treatment|June 26, 2004
Estrogen responsiveness of IBEP-2, a new human cell line derived from breast carcinomaFabrice Journé, Jean-Jacques Body, Guy Leclercq, et al.
Molecular Endocrinology (Baltimore, Md.)|March 27, 2012
Palmitoylation regulates 17β-estradiol-induced estrogen receptor-α degradation and transcriptional activityPiergiorgio La Rosa, Valeria Pesiri, Guy Leclercq, et al.
Pageof 6